The use of Caenorhabditis elegans in Molecular Neuropharmacology

International Review of Neurobiology

Volumn 62, Issue , 2004, Pages 195-212

  Bettinger, Jill C ^a   Carnell, Lucinda ^a   Davies, Andrew G ^a   McIntire, Steven L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ANIMAL MODEL; CAENORHABDITIS ELEGANS; DRUG EFFECT; GENETICS; MOLECULAR BIOLOGY; NERVOUS SYSTEM; NEUROPHARMACOLOGY; REVIEW;

ANIMALS; CAENORHABDITIS ELEGANS; MODELS, ANIMAL; MOLECULAR BIOLOGY; NERVOUS SYSTEM; NEUROPHARMACOLOGY;

EID: 16544370069     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0074-7742(04)62007-1     Document Type: Article

References (89)

1. Anderson P. Mutagenesis. In: Epstein H.F., and Shakes D.C. (Eds). "C. elegans: Modern Biological Analysis of an Organism" (1995), Academic Press, New York 31-54
2. Avery L. The genetics of feeding in Caenorhabditis elegans. Genetics 133 (1993) 897-917
3. Bamber B.A., Beg A.A., Twyman R.E., and Jorgensen E.M. The Caenorhabditis elegans unc-49 locus encodes multiple subunits of a heteromultimeric GABA receptor. J. Neurosci 19 (1999) 5348-5359
4. Bargmann C.I. Neurobiology of the Caenorhabditis elegans genome. Science 282 (1998) 2028-2033
5. Blackhall W.J., Pouliot J.F., Prichard R.K., and Beech R.N. Haemonchus contortus: Selection at a glutamate-gated chloride channel gene in ivermectin- and moxidectin-selected strains. Exp. Parasitol 90 (1998) 42-48
6. Boswell M.V., Morgan P.G., and Sedensky M.M. Interaction of GABA and volatile anesthetics in the nematode Caenorhabditis elegans. FASEB. J 4 (1990) 2506-2510
7. Brockie P.J., Mellem J.E., Hills T., Madsen D.M., and Maricq A.V. The C. elegans glutamate receptor subunit NMR-1 is required for slow NMDA-activated currents that regulate reversal frequency during locomotion. Neuron 31 (2001) 617-630
8. Brownlee D.J., and Fairweather I. Exploring the neurotransmitter labyrinth in nematodes. Trends Neurosci 22 (1999) 16-24
9. C. elegans Sequencing Consortium. Genome sequence of the nematode C. elegans: A platform for investigating biology. The C. elegans Sequencing Consortium. Science 282 (1998) 2012-2018
10. Chalfie M., Tu Y., Euskirchen G., Ward W.W., and Prasher D.C. Green fluorescent protein as a marker for gene expression. Science 263 (1994) 802-805
11. Cheeseman C.L., Delany N.S., Woods D.J., and Wolstenholme A.J. High-affinity ivermectin binding to recombinant subunits of the Haemonchus contortus glutamate-gated chloride channel. Mol. Biochem. Parasitol 114 (2001) 161-168
12. Choy R.K., and Thomas J.H. Fluoxetine-resistant mutants in C. elegans define a novel family of transmembrane proteins. Mol. Cell 4 (1999) 143-152
13. Chu B., Dopico A.M., Lemos J.R., and Treistman S.N. Ethanol potentiation of calcium-activated potassium channels reconstituted into planar lipid bilayers. Mol. Pharmacol 54 (1998) 397-406
14. Cully D.F., Vassilatis D.K., Liu K.K., Paress P.S., Van der Ploeg L.H., Schaeffer J.M., and Arena J.P. Cloning of an avermectin-sensitive glutamate-gated chloride channel from Caenorhabditis elegans. Nature 371 (1994) 707-711
15. Davies A.G., Bettinger J.C., Thiele T.R., Judy M.E., and McIntire S.L. Natural variation in the npr-1 gene modifies ethanol responses of wild strains of C. elegans. Neuron 42 (2004) 731-743
16. Davies A.G., Pierce-Shimomura J.T., Kim H., VanHoven M.K., Thiele T.R., Bonci A., Bargmann C.I., and McIntire S.L. A central role of the BK potassium channel in behavioral responses to ethanol in C. elegans. Cell 115 (2003) 655-666
17. de Bono M., and Bargmann C.I. Natural variation in a neuropeptide Y receptor homolog modifies social behavior and food response in C. elegans. Cell 94 (1998) 679-689
18. Dent J.A., Davis M.W., and Avery L. avr-15 encodes a chloride channel subunit that mediates inhibitory glutamatergic neurotransmission and ivermectin sensitivity in Caenorhabditis elegans. EMBO J 16 (1997) 5867-5879
19. Dent J.A., Smith M.M., Vassilatis D.K., and Avery L. The genetics of invermectin resistance in Caenorhabditis elegans. Proc. Natl. Acad. Sci. USA 97 (2000) 2674-2679
20. Diamond I., and Gordon A.S. Cellular and molecular neuroscience of alcoholism. Physiol. Rev 77 (1997) 1-20
21. ++. J. Pharmacol. Exp. Ther 284 (1998) 258-268
22. + channels in isolated neurohypophysial terminals. Mol. Pharmacol 49 (1996) 40-48
23. Duerr J.S., Frisby D.L., Gaskin J., Duke A., Asermely K., Huddleston D., Eiden L.E., and Rand J.B. The cat-1 gene of Caenorhabditis elegans encodes a vesicular monoamine transporter required for specific monoamine-dependent behaviors. J. Neurosci 19 (1999) 72-84
24. Dzitoyera S., Dimitrijevic N., and Manev H. Identification of a novel Drosophia gene, beltless, using injectable embryonic and adult RNA interference (RNAi). BMC Genomics 4 (2003) 33-46
25. Edgley M., D'Souza A., Moulder G., McKay S., Shen B., Gilchrist E., Moerman D., and Barstead R. Improved detection of small deletions in complex pools of DNA. Nucleic Acids Res 30 (2002) e52
26. Ereshefsky L., Riesenman C., and Lam Y.W. Antidepressant drug interactions and the cytochrome P450 system. The role of cytochrome P450 2D6. Clin. Pharmacokinet 29 Suppl. 1 (1995) 10-18 discussion 18-19
27. Fire A., Harrison S.W., and Dixon D. A modular set of lacZ fusion vectors for studying gene expression in Caenorhabditis elegans. Gene 93 (1990) 189-198
28. Fleming J.T., Squire M.D., Barnes T.M., Tornoe C., Matsuda K., Ahnn J., Fire A., Sulston J.E., Barnard E.A., Sattelle D.B., and Lewis J.A. Caenorhabditis elegans levamisole resistance genes lev-1, unc-29, and unc-38 encode functional nicotinic acetylcholine receptor subunits. J. Neurosci 17 (1997) 5843-5857
29. Garcia-Colunga J., Awad J.N., and Miledi R. Blockage of muscle and neuronal nicotinic acetylcholine receptors by fluoxetine (Prozac). Proc. Natl. Acad. Sci. USA 94 (1997) 2041-2044
30. Goodman M.B., Hall D.H., Avery L., and Lockery S.R. Active currents regulate sensitivity and dynamic range in C. elegans neurons. Neuron 20 (1998) 763-772
31. Ca channels. Eur. J. Neurosci 14 (2001) 1246-1256
32. Hamdan F.F., Ungrin M.D., Abramovitz M., and Ribeiro P. Characterization of a novel serotonin receptor from Caenorhabditis elegans: Cloning and expression of two splice variants. J. Neurochem 72 (1999) 1372-1383
33. Harris R.A. Ethanol actions on multiple ion channels: Which are important?. Alcohol. Clin. Exp. Res 23 (1999) 1563-1570
34. Hart A.C., Sims S., and Kaplan J.M. Synaptic code for sensory modalities revealed by C. elegans GLR-1 glutamate receptor. Nature 378 (1995) 82-85
35. Hejmadi M.V., Jagannathan S., Delany N.S., Coles G.C., and Wolstenholme A.J. L-glutamate binding sites of parasitic nematodes: An association with ivermectin resistance?. Parasitology 120 Pt. 5 (2000) 535-545
36. Hobson R.J., Geng J., Gray A.D., and Komuniecki R.W. SER-7b, a constitutively active Gαs coupled 5-HT7-like receptor expressed in the Caenorhabditis elegans M4 pharyngeal motorneuron. J. Neurochem 87 (2003) 22-29
37. Horvitz H.R., Chalfie M., Trent C., Sulston J.E., and Evans P.D. Serotonin and octopamine in the nematode Caenorhabditis elegans. Science 216 (1982) 1012-1014
38. + channels of clonal pituitary (GH3) cells. J. Membr. Biol 157 (1997) 237-245
39. Kamath R.S., Fraser A.G., Dong Y., Poulin G., Durbin R., Gotta M., Kanapin A., Le Bot N., Moreno S., Sohrmann M., Welchman D.P., Zipperlen P., and Ahringer J. Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nature 421 (2003) 231-237
40. Kass I.S., Larsen D.A., Wang C.C., and Stretton A.O. Ascaris suum: Differential effects of avermectin B1a on the intact animal and neuromuscular strip preparations. Exp. Parasitol 54 (1982) 166-174
41. Kayser E.B., Hoppel C.L., Morgan P.G., and Sedensky M.M. A mutation in mitochondrial complex I increases ethanol sensitivity in Caenorhabditis elegans. Alcohol. Clin. Exp. Res 27 (2003) 584-592
42. Kayser E.B., Morgan P.G., and Sedensky M.M. GAS-1: A mitochondrial protein controls sensitivity to volatile anesthetics in the nematode Caenorhabditis elegans. Anesthesiology 90 (1999) 545-554
43. Kerr R., Lev-Ram V., Baird G., Vincent P., Tsien R.Y., and Schafer W.R. Optical imaging of calcium transients in neurons and pharyngeal muscle of C. elegans. Neuron 26 (2000) 583-594
44. Kwon J.Y., Hong M., Choi M.S., Kang S., Duke K., Kim S., Lee S., and Lee J. Ethanol-response genes and their regulation analyzed by a microarray and comparative genomic approach in the nematode Caenorhabditis elegans. Genomics 83 (2004) 600-614
45. Le Jambre L.F., Gill J.H., Lenane I.J., and Baker P. Inheritance of avermectin resistance in Haemonchus contortus. Int. J. Parasitol 30 (2000) 105-111
46. Leonardi E.T., and Azmitia E.C. MDMA (ecstasy) inhibition of MAO type A and type B: Comparisons with fenfluramine and fluoxetine (Prozac). Neuropsychopharmacology 10 (1994) 231-238
47. Lewis J.A., Fleming J.T., McLafferty S., Murphy H., and Wu C. The levamisole receptor a cholinergic receptor of the nematode Caenorhabditis elegans. Mol. Pharmacol 31 (1987) 185-193
48. Lewis J.A., Wu C.H., Levine J.H., and Berg H. Levamisole-resistant mutants of the nematode Caenorhabditis elegans appear to lack pharmacological acetylcholine receptors. Neuroscience 5 (1980) 967-989
49. Maricq A.V., Peckol E., Driscoll M., and Bargmann C.I. Mechanosensory signalling in C. elegans mediated by the GLR-1 glutamate receptor. Nature 378 (1995) 78-81
50. Martin R.J. An electrophysiological preparation of Ascaris suum pharyngeal muscle reveals a glutamate-gated chloride channel sensitive to the avermectin analogue, milbemycin D. Parasitology 112 Pt. 2 (1996) 247-252
51. Mello C.C., Kramer J.M., Stinchcomb D., and Ambros V. Efficient gene transfer in C. elegans: Extrachromosomal maintenance and integration of transforming sequences. EMBO J 10 (1991) 3959-3970
52. Miller K.G., Alfonso A., Nguyen M., Crowell J.A., Johnson C.D., and Rand J.B. A genetic selection for Caenorhabditis elegans synaptic transmission mutants. Proc. Natl. Acad. Sci. USA 93 (1996) 12593-12598
53. Morgan P.G., and Sedensky M.M. Mutations affecting sensitivity to ethanol in the nematode, Caenorhabditis elegans. Alcohol. Clin. Exp. Res 19 (1995) 1423-1429
54. 0 decreases the abundance of UNC-13 at release sites. Neuron 24 (1999) 231-242
55. Olde B., and McCombie W.R. Molecular cloning and functional expression of a serotonin receptor from Caenorhabditis elegans. J. Mol. Neurosci 8 (1997) 53-62
56. Pacher P., Magyar J., Szigligeti P., Banyasz T., Pankucsi C., Korom Z., Ungvari Z., Kecskemeti V., and Nanasi P.P. Electrophysiological effects of fluoxetine in mammalian cardiac tissues. Naunyn Schmiedebergs Arch. Pharmacol 361 (2000) 67-73
57. Pemberton D.J., Franks C.J., Walker R.J., and Holden-Dye L. Characterization of glutamate-gated chloride channels in the pharynx of wild-type and mutant Caenorhabditis elegans delineates the role of the subunit GluCl-alpha2 in the function of the native receptor. Mol. Pharmacol 59 (2001) 1037-1043
58. Rae J.L., Rich A., Zamudio A.C., and Candia O.A. Effect of Prozac on whole cell ionic currents in lens and corneal epithelia. Am. J. Physiol 269 (1995) C250-C256
59. Raizen D.M., and Avery L. Electrical activity and behavior in the pharynx of Caenorhabditis elegans. Neuron 12 (1994) 483-495
60. Rand J.B., and Johnson C.D. Genetic pharmacology: interactions between drugs and gene products in C. elegans. In: Epstein H.F., and Shakes D.C. (Eds). "Caenorhabditis elegans: Modern Biological Analysis of An Organism" (1995), Academic Press, San Diego, Calif 187-204
61. Ranganathan R., Sawin E.R., Trent C., and Horvitz H.R. Mutations in the Caenorhabditis elegans serotonin reuptake transporter MOD-5 reveal serotonin-dependent and -independent activities of fluoxetine. J. Neurosci 21 (2001) 5871-5884
62. Richmond J.E., and Jorgensen E.M. One GABA and two acetylcholine receptors function at the C. elegans neuromuscular junction. Nat. Neurosci 2 (1999) 791-797
63. Riddle D.L., Blumenthal T., Meyer B.J., and Priess J.R. C. Elegans II (1997), Cold Spring Harbor Laboratory Press, Plainview, New York
64. Ruvkun G. Patterning the nervous system. In: Riddle D.L., Blumenthal T., Meyer B.J., and Priess J.R. (Eds). "C. Elegans II" (1997), Cold Spring Harbor Laboratory Press, Plainview, New York 543-581
65. Sanyal S., Wintle R.F., Kindt K.S., Nuttley W.M., Arvan R., Fitzmaurice P., Bigras E., Merz D.C., Hebert T.E., Van Der Kooy D., Schafer W.R., Culotti J.G., and Van Tol H.H. Dopamine modulates the plasticity of mechanosensory responses in Caenorhabditis elegans. EMBO J 23 (2004) 473-482
66. Sawin E.R., Ranganathan R., and Horvitz H.R. C. elegans locomotry rate is modulated by the environment through a dopaminergic pathway and by experience through a serotonergic pathway. Neuron 26 (2000) 619-631
67. Schaeffer J.M., and Haines H.W. Avermectin binding in Caenorhabditis elegans. A two-state model for the avermectin binding site. Biochem. Pharmacol 38 (1989) 2329-2338
68. Schafer W.R., and Kenyon C.J. A calcium-channel homologue required for adaptation to dopamine and serotonin in Caenorhabditis elegans. Nature 375 (1995) 73-78
69. Schuckit M.A. Low level of response to alcohol as a predictor of future alcoholism. Am. J. Psychiatry 151 (1994) 184-189
70. Shreffler W., Magardino T., Shekdar K., and Wolinsky E. The unc-8 and sup-40 genes regulate ion channel function in Caenorhabditis elegans motorneurons. Genetics 139 (1995) 1261-1272
71. Simmer F., Moorman C., Van Der Linden A.M., Kuijk E., Van Den Berghe P.V., Kamath R., Fraser A.G., Ahringer J., and Plasterk R.H. Genome-wide RNAi of C. elegans using the hypersensitive rrf-3 strain reveals novel gene functions. PLoS Biol 1 (2003) E12
72. Starich T.A., Herman R.K., Kari C.K., Yeh W.H., Schackwitz W.S., Schuyler M.W., Collet J., Thomas J.H., and Riddle D.L. Mutations affecting the chemosensory neurons of Caenorhabditis elegans. Genetics 139 (1995) 171-188
73. Stinchcomb D.T., Shaw J.E., Carr S.H., and Hirsh D. Extrachromosomal DNA transformation of Caenorhabditis elegans. Mol. Cell. Biol 5 (1985) 3484-3496
74. Stokes P.E., and Holtz A. Fluoxetine tenth anniversary update: The progress continues. Clin. Ther 19 (1997) 1135-1250
75. Sulston J.E., and Horvitz H.R. Post-embryonic cell lineages of the nematode, Caenorhabditis elegans. Dev. Biol 56 (1977) 110-156
76. Suo S., Sasagawa N., and Ishiura S. Identification of a dopamine receptor from Caenorhabditis elegans. Neurosci. Lett 319 (2002) 13-16
77. Sze J.Y., Victor M., Loer C., Shi Y., and Ruvkun G. Food and metabolic signalling defects in a Caenorhabditis elegans serotonin-synthesis mutant. Nature 403 (2000) 560-564
78. Thiele T.E., and Badia-Elder N.E. A role for neuropeptide Y in alcohol intake control: Evidence from human and animal research. Physiol. Behav 79 (2003) 95-101
79. Thomas D., Gut B., Wendt-Nordahl G., and Kiehn J. The antidepressant drug fluoxetine is an inhibitor of human ether-a-go-go-related gene (HERG) potassium channels. J. Pharmacol. Exp. Ther 300 (2002) 543-548
80. Treinin M., and Chalfie M. A mutated acetylcholine receptor subunit causes neuronal degeneration in C. elegans. Neuron 14 (1995) 871-877
81. van Swinderen B., Galifianakis A., and Crowder C.M. Common genetic determinants of halothane and isoflurane potencies in Caenorhabditis elegans. Anesthesiology 89 (1998) 1509-1517
82. Vassilatis D.K., Arena J.P., Plasterk R.H., Wilkinson H.A., Schaeffer J.M., Cully D.F., and Van der Ploeg L.H. Genetic and biochemical evidence for a novel avermectin-sensitive chloride channel in Caenorhabditis elegans. Isolation and characterization. J. Biol. Chem 272 (1997) 33167-33174
83. Waggoner L.E., Dickinson K.A., Poole D.S., Tabuse Y., Miwa J., and Schafer W.R. Long-term nicotine adaptation in Caenorhabditis elegans involves PKC-dependent changes in nicotinic receptor abundance. J. Neurosci 20 (2000) 8802-8811
84. Wang Z.W., Saifee O., Nonet M.L., and Salkoff L. SLO-I potassium channels control quantal content of neurotransmitter release at the C. elegans neuromuscular junction. Neuron 32 (2001) 867-881
85. Weinshenker D., Garriga G., and Thomas J.H. Genetic and pharmacological analysis of neurotransmitters controlling egg laying in C. elegans. J. Neurosci 15 (1995) 6975-6985
86. White J.G., Southgate E., Thomson J.N., and Brenner S. The structure of the ventral nerve cord of Caenorhabditis elegans. Philos. Trans. R. Soc. Lond. B Biol. Sci 275 (1976) 327-348
87. White J.G., Southgate E., Thomson J.N., and Brenner S. The structure of the nervous system of the nematode C. elegans. Philos. Trans. R. Soc. Lond. B Biol. Sci 314 (1986) 1-340
88. Wicks S.R., Yeh R.T., Gish W.R., Waterston R.H., and Plasterk R.H. Rapid gene mapping in Caenorhabditis elegans using a high density polymorphism map. Nat. Genet 28 (2001) 160-164
89. Wong D.T., Reid L.R., Bymaster F.P., and Threlkeld P.G. Chronic effects of fluoxetine, a selective inhibitor of serotonin uptake, on neurotransmitter receptors. J. Neural Transm 64 (1985) 251-269